abstract |
The invention relates to therapies for (auto)immune diseases. Synthesis or presence of apoptotic activity in cells causing or related to (auto)immune diseases, such as synoviocytes in rheumatoid arthritis, will result in the induction of apoptosis. The invention also relates to gene-delivery vehicles, which comprise nucleic acid molecules encoding apoptosis-inducing proteins with apoptin-like activity. |